{"listing":{"listing_type":"company","name":"Nouscom","slug":"nouscom","tagline":"Clinical-stage biotech developing off-the-shelf neoantigen cancer immunotherapies","description":"Nouscom is a Basel-based clinical-stage biotech founded in 2015 that develops next-generation neoantigen-targeted immunotherapies, with a focus on cancer interception. Its lead programme NOUS-209 is an investigational off-the-shelf neoantigen-based immunotherapy for people with Lynch Syndrome. Marina Udier is CEO. In October 2026 it closed an oversubscribed 120 million euro Series D co-led by M Ventures and Revelation Partners, with new investors Angelini Ventures, the EIB and Neva SGR and existing investors including 5AM Ventures, Versant Ventures and EQT Life Sciences.","url":"https://nouscom.com/","is_stealth":false,"normalized_domain":"nouscom.com","normalized_url_key":"nouscom.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Series D coverage (EU-Startups)","url":"https://www.eu-startups.com/2026/10/switzerlands-nouscom-bags-e120-million-to-bring-innovative-cancer-immunotherapy-closer-to-clinical-trials/","platform":"other"}],"entry_points":[{"kind":"homepage","url":"https://nouscom.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nouscom.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Oncology","Immunotherapy","Life Sciences"],"stage":"series-b+","founded_year":2015,"location":"Basel, Switzerland","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-10-19T10:41:55.498Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-19T10:41:55.498Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"immunotherapy","name":"Immunotherapy","note":null,"profile_url":"/industries/immunotherapy"},{"kind":"industry","slug":"life-sciences","name":"Life Sciences","note":null,"profile_url":"/industries/life-sciences"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}]}}